Uncategorized
Ocular Therapeutix™ to Present at the 2019 Wells Fargo Healthcare Conference
BEDFORD, Mass.--(BUSINESS WIRE)--<a href="https://twitter.com/search?q=%24OCUL&src=ctag" target="_blank">$OCUL</a> <a href="https://twitter.com/hashtag/OCUTX?src=hash" target="_blank">#OCUTX</a>--Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Antony Mattessich, President and Chief Executive Officer of Ocular Therapeutix, will give a company presentation on Thursday, September 5th at 2:30 p.m. EDT at the 2019 Wells Fargo Healthcare Conference at the Westin Copley Place Hotel in Boston, MA.